☰

Stacy M. Lloyd, Ph.D. - Publications

Affiliations: 
2010 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Genetics, Epidemiology, Public Health
Tree Info Similar researchers PubMed Report error

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Nevarez L, Hovick SR, Enard KR, Lloyd SM, Kahlor LA. Race/Ethnic Variations in Predictors of Health Consciousness Within the Cancer Prevention Context. American Journal of Health Promotion : Ajhp. 890117120904000. PMID 32037851 DOI: 10.1177/0890117120904000  0.3
2020 Charles C, Gohlke J, Lloyd S, Henderson J, Karanam B, Navone N, Kittles R, Ambs S, Michailidis G, Putluri N, Sreekumar A. Abstract A095: Metabolic rewiring in African-American prostate cancer: A role for adenosine-inosine axis in tumor progression Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-A095  0.358
2020 Hooker SE, Bathina M, Lloyd S, Gorjala P, Mitra R, Kimbro KS, Kittles RA. Abstract B073: Estimating genetic ancestry of commonly used cancer cell lines Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-B073  0.32
2019 Gohlke JH, Lloyd SM, Basu S, Putluri V, Vareed SK, Rasaily U, Piyarathna DWB, Fuentes H, Rajendiran TM, Dorsey TH, Ambati CR, Sonavane R, Karanam B, Bhowmik SK, Kittles R, et al. Methionine-Homocysteine Pathway in African-American Prostate Cancer. Jnci Cancer Spectrum. 3: pkz019. PMID 31360899 DOI: 10.1093/Jncics/Pkz019  0.411
2019 Piyarathna DWB, Balasubramanian A, Arnold JM, Lloyd SM, Karanam B, Castro P, Ittmann MM, Putluri N, Navone N, Jones JA, Yu W, Sandulache VC, Sikora AG, Michailidis G, Sreekumar A. ERR1 and PGC1α associated mitochondrial alterations correlate with pan-cancer disparity in African Americans. The Journal of Clinical Investigation. 130. PMID 30920960 DOI: 10.1172/Jci127579  0.405
2018 Lloyd SM, Gohlke JH, Basu S, Putluri V, Vareed SK, Martin RS, Rajendiran T, Dorsey TA, Prasad B, Sonavane R, Rasaily U, Henderson J, Karanam B, Venghatakrishnan H, Bhowmik S, et al. Abstract B92: Metabolomic landscape of African American prostate cancer: Insights into the biologic basis of the racial disparity Cancer Epidemiology, Biomarkers & Prevention. 27. DOI: 10.1158/1538-7755.Disp17-B92  0.41
2016 Kaushik AK, Shojaie A, Panzitt K, Sonavane R, Venghatakrishnan H, Manikkam M, Zaslavsky A, Putluri V, Vasu VT, Zhang Y, Khan AS, Lloyd S, Szafran AT, Dasgupta S, Bader DA, et al. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nature Communications. 7: 11612. PMID 27194471 DOI: 10.1038/Ncomms11612  0.358
2016 Lloyd SM, Gohlke J, Basu S, Bhowmik S, Putluri V, Krishnapurnam R, Rajapakshe K, Coarfa C, Guha N, Deepak S, Padmanabhan A, Sayeeduddin M, Castro P, Ittmann M, Palapattu G, et al. Abstract A65: An integromics approach identifies immune escape as a potential mechanism for prostate cancer disparities Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-A65  0.385
2016 Kaushik AK, Shojaie A, Panzitt K, Sonavane R, Venghatakrishnan H, Manikkam M, Zaslavsky A, Putluri V, Vasu V, Zhang Y, Khan A, Lloyd S, Szafran A, Dasgupta S, Bader D, et al. Abstract 1056: Inhibition of hexose monophosphate pathway promotes castration resistant prostate cancer Cancer Research. 76: 1056-1056. DOI: 10.1158/1538-7445.Am2016-1056  0.35
2015 Lloyd SM, Arnold J, Sreekumar A. Metabolomic profiling of hormone-dependent cancers: a bird's eye view. Trends in Endocrinology and Metabolism: Tem. 26: 477-85. PMID 26242817 DOI: 10.1016/J.Tem.2015.07.001  0.448
2015 Hall MB, Carter-Francique AR, Lloyd SM, Eden TM, Zuniga AV, Guidry JJ, Jones LA. Bias within: Examining the role of cultural competence perceptions in Mammography Adherence Sage Open. 5. DOI: 10.1177/2158244015576547  0.359
2013 Lloyd SM, Lopez M, El-Zein R. Cytokinesis-blocked micronucleus cytome assay and spectral karyotyping as methods for identifying chromosome damage in a lung cancer case-control population. Genes, Chromosomes & Cancer. 52: 694-707. PMID 23630028 DOI: 10.1002/Gcc.22065  0.39
2013 Dallal C, Garte S, Ragin C, Chen J, Lloyd S, Modugno F, Weissfeld J, Taioli E. Plasma leptin levels, LEPR Q223R polymorphism and mammographic breast density: a cross-sectional study. The International Journal of Biological Markers. 28: 161-7. PMID 23564622 DOI: 10.5301/Jbm.5000016  0.492
2013 Walsh KM, Gorlov IP, Hansen HM, Wu X, Spitz MR, Zhang H, Lu EY, Wenzlaff AS, Sison JD, Wei C, Lloyd SM, Chen W, Frazier ML, Seldin MF, Bierut LJ, et al. Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 251-60. PMID 23221128 DOI: 10.1158/1055-9965.Epi-12-1007-T  0.357
2012 Walsh KM, Amos CI, Wenzlaff AS, Gorlov IP, Sison JD, Wu X, Spitz MR, Hansen HM, Lu EY, Wei C, Zhang H, Chen W, Lloyd SM, Frazier ML, Bracci PM, et al. Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans. Oncotarget. 3: 1428-38. PMID 23232035 DOI: 10.18632/Oncotarget.746  0.384
2012 Lloyd SM, Lopez M, El-Zein R. Abstract LB-185: Cytokinesis-blocked micronuclei Assay (CBMN) as a biological cancer risk assessment tool Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-185  0.414
2010 Lloyd SM, Diergaarde B. Abstract A2: Genetic variation in estrogen receptor genes and mammographic breast density Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A2  0.442
2009 Im A, Vogel VG, Ahrendt G, Lloyd S, Ragin C, Garte S, Taioli E. Urinary estrogen metabolites in women at high risk for breast cancer. Carcinogenesis. 30: 1532-5. PMID 19502596 DOI: 10.1093/Carcin/Bgp139  0.548
2009 Im A, Vogel V, Ahrendt G, Lloyd S, Garte S, Ragin C, Taioli E. Urinary estrogen metabolites in patients at high risk for breast cancer. Cancer Research. 69: 4080. DOI: 10.1158/0008-5472.Sabcs-4080  0.468
2008 Im A, Vogel VG, Ahrendt G, Lloyd S, Garte S, Ragin C, Taioli E. Urinary estrogen metabolites in patients at high risk for breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 1520. PMID 27948342 DOI: 10.1200/Jco.2008.26.15_Suppl.1520  0.46
Show low-probability matches.